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The crude methanolic extract and various fractions derived from the aerial parts of Myrsine africana 
were screened in vitro for possible phytotoxic, antibacterial and haemagglutination activities. Moderate 
phytotoxic activity (31.25 %) was observed against Lemna minor L at 1000 µg/ml by chloroform fraction 
(CHCl3). The crude methanolic extract and CHCl3 fraction showed good antibacterial activity against 
Klebsiella pneumoniae (MIC50 = 2.45 and 2.1 mg/ml respectively). The crude methanolic extract and other 
fractions showed moderate activity against tested bacterial strains. The CHCl3 and aqueous fractions 
showed no activity against Escherichia coli. Similarly, the ethyl acetate (EtOAc) and butanol (BuOH) 
fractions were found to be non active against Bacillus pumilus and Enterobacter aerogenes, 
respectively. Moderate haemagglutination activity was observed against human red blood cells (RBCs) 
of blood group AB
- 
by crude methanolic extract and CHCl3 fraction and against AB
+ 
by aqueous fraction, 
respectively. The plant specie can be a source of antibacterial agent(s) and phytolectins. 
 





In past decades, higher plants are well recognized for 
their ability to produce a wide spectrum of natural 
products with interesting bioactivities (Liu et al., 2007; 
Morita et al., 2006; Pepeljnjak et al., 2005; Tiew et al., 
2003). Myrsine africana, locally called Babrang, belongs 
to the family Myrsinaceae, a large family of about 35 
genera and nearly 1000 species, widespread mainly in 
the tropical and subtropical regions (Nasir and Ali, 1979), 
Traditionally, the plant is used as fragrance in tea, spices, 
carminative, appetizer and flavoring agent. Its fruits are 
edible and locally used as an anthelmintic (Zabta et al., 
2003; Kokwaro, 1993; Beentje, 1994; Desta, 1995) for 
the treatment of diarrhea, rheumatism, toothache, 
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Abbreviations: EtOAc, Ethyl acetate; BuOH, butanol; DMSO, 
dimethyl sulfoxide. 
(Zhong, 1985).  The alcoholic extract of twigs and  leaves 
of the plants possesses significant inhibitory activities 
against walker intramuscular carcinosarcoma in rates 
(Kupchan et al., 1969). Preparations from the mixture of 
dried fruits and leaves of M. africana in water has shown 
77% efficacy against Haemonchus, Trichostrogylus and 
Oesophagostomum spp. (Gathuma et al., 2004). Extracts 
of leaves and fruits of M. africana and fruits of Rapanea 
melanophloeos were not efficacious against Haemonchus 
contortus in sheep (Githiori et al., 2002). The ethanolic 
extract of the fruits showed lethal action against tape 
worms, while ethereal, alcoholic and aqueous extracts 
had a marked purgative activity in albino rats (Kakrani et 
al., 1983). Emodin and 2-hydroxychrysophanol have 
been isolated from ethanolic extract of the roots of the 
plants (Xiao-hua and Mc Laughlin, 1989). Similarly, 
saponin isolated from the leaves of Maesa lanceolata has 
shown virucidal, haemolytic and anthelmintic activities 
(Apers et al., 2001; Bagalwa and Chifundera, 2007). 
Embelin isolated from R. melanophloeos acts as an anti 
feedant   to   Schistocerca  gregaria,  and  is  larvicidal  to  




Aedes egyptii larvae (Midiwo et al., 1995). Anti-fertility 
activity of Embelia ribes have also  been  reported  (Arora 
et al., 1971). The seed extract of the Rapanea guinensis 
Aubl gave non specific agglutinating reactions with 
human bloods (Schertz et al., 1960). Based on the 
reported literature of M. africana and other plants of the 
family, we screened M. africana for possible 
pharmacological/biological activities.  
 
 




Aerial parts of M. africana (Myrsinaceae), were collected from 
Hazara division, in December, 2007 – January, 2008. The plant 
was identified by Professor Dr. Habib Ahmad, Plant Taxonomist, 




The extraction of crude methanolic extract from the plant material 
was carried out as per Ahmed et al. (2009). The shade dried plant 
materials were chopped into small pieces and grinded to fine 
powder by using electric grinder. The powdered plant material (7.6 
kg) was soaked in commercial grade methanol for 15 days at room 
temperature and was subjected to occasional shaking. After 15 
days, methanol soluble materials were filtered off. All filtrates were 
combined and concentrated under vacuum at 40°C using a rotary 





The crude methanolic extract (750 g) was suspended in distilled 
water (400 ml) and partitioned with n-hexane (3 x 400 ml), CHCl3 (3 x 
400 ml), EtOAc (3 x 400 ml) and BuOH (3 x 400 ml) to yield n-hexane 
(50 g), CHCl3 (45 g), EtOAc (255 g), BuOH(190 g) and aqueous (210 







The phytotoxic activity of the test samples (methanolic crude extract 
and fractions) were screened against Lemna minor L. (McLaughlin 
et al., 1991), available at the department of Botany, University of 
Peshawar. Stock solutions of the test samples were prepared in 
methanol at concentration of 20 mg/ml and E-medium was pre-
pared for the growth of L. minor. 10, 100 and 1000 µg/ml from the 
stock solution were introduced into three flasks, one for each 
sample and left at room temperature till the organic solvent was 
evaporated. 20 ml of the E-medium and sixteen healthy plants with 
a rosette of three fronds were added to all flasks and incubated at 
28 ± 1°C for seven days. Paraquat at a concentration 0.015 µg/ml 
was used as standard growth inhibitor and three flasks containing 






Determination of percent inhibition  
 





were screened for possible antibacterial activity against various 
human pathogens including Escherichia coli, Pseudomonas 
aeruginosa, Staphylococcus aureus, Staphylococcus epidermidis, 
Salmonella typhi, Bacillus pumilus, Klebsiella pneumoniae, 
Streptococcus pneumoniae and Enterobacter aerogenes as per our 
reported procedure (Ahmed et al., 2009). Test organisms were 
inoculated to 10 ml nutrients broth (Sigma-Aldrich, Germany) and 
incubated at 37°C. After 24 h, 0.6 ml from the test organism culture 
was added to 60 ml of molten agar at 45°C, mixed and transfered to 
a sterile petri dish (for the 9 cm petri dish, 0.2 ml of the culture was 
added to 20 ml of agar). The agar plates were allowed to harden 
and wells were dug in the plates at equal distance. Agar plugs were 
removed from the plates to open the wells. Stock solutions of the 
samples were prepared at concentration of 3 mg/ml in sterile 
dimethyl sulfoxide (DMSO < 1%); 100 µl of the test samples were 
loaded to their respective wells. Amoxicillin and DMSO (<1%) were 
used as positive and negative controls, respectively. For better 
diffusion of the test samples to media, the plates were left for two to 
three hours undisturbed inside the laminar air flow, and then 




Determination of minimum inhibitory concentration (MIC)  
 
After recording the zone of inhibitions, experiments were performed 
to determine the MIC50, using slightly modified procedure of Banso 
(2009). This was performed by taking 4 ml of nutrient broth in sterile 
test tubes inoculated with 18 - 24 h old culture of the test orga-
nisms. 300, 500, 700 and 900 µl from the stock solution (3 mg/ml) 
of the samples were poured into the test tubes containing test 
pathogens. After 24 h of incubation at 37°C, results were recorded 





Haemagglutination activity of the crude extract and fractions was 
tested against human erythrocyte blood groups ABO (Naqvi et al., 
1992). Stock solution of the test sample was prepared at concen-
tration of 1 mg/ml and each solution was serially diluted. Fresh 
blood was collected from healthy persons, centrifuged and the 
erythrocytes were separated. 2% erythrocyte suspension was 
prepared in phosphate buffer (pH 7.4) of all blood groups. 1 ml of 
the test sample dilution was taken with 1 ml of 2% erythrocyte and 
incubated at 25°C. After incubation, the results were noted. Smooth 
button formation in bottom indicated negative activity, while a rough 
granular deposition at bottom showed positive activity. The intensity 
of haemagglutination was determined from the extent of deposition.  
 
 
RESULTS AND DISCUSSION 
 
In Pakistan, the rural population still mainly depends on 
the traditional/indigenous system of medicine for their 
health related matters (Khattak et al., 1985). Keeping in 
view the traditional/medicinal uses of the plant and 
previous work done, we carried out the in vitro biological 





Herbicides of the plants’ origin are friendly to the 
environment,   and   this  necessitates  their  search.  The  






Figure 1. Phytotoxic activity of the crude methanolic extract and various fractions of M. africana against L. minor. 




phytotoxic results of the plant crude methanolic extract 
and various fractions against L. minor are summarized in 
Figure 1. The methanolic extract showed (25 and 6.25%), 
n-hexane (25 and 12.50%), CHCl3 (31.25 and 6.25%), 
EtOAc (18.75 and 6.25%), BuOH (25 and 18.75%) and 
aqueous (25 and 12.5%) growth inhibition at concen-
trations of 1000 and 100 µg/m, respectively. While no 






Crude methanolic extract and various fractions of M. 
africana were screened against the said test pathogens 
for possible antibacterial activity. The results are sum-
marized in Figure 2. Order of the antibacterial activity of 
the crude methanolic extract and fractions against E. coli 
crude extract (60.86%) > n-hexane = EtOAc (52.17%) > 
BuOH (47.82%) > CHCl3 and aqueous fractions shows 
no activity against E. coli. Against S. epidermidis; crude 
extract (39.39%) > n-hexane = aqueous (36.36%) > 
CHCl3 = BuOH (33.33%) > EtOAc (30.30%). The order of 
activity against S. typhi was: crude extract (53.57%) > 
aqueous (52.57%) > BuOH (50.0%) > EtOAc (46.42%) > 
n-hexane (42.85%) > CHCl3 (39.28%). Against S. 
pneumoniae;  crude  extract  (57.69%) > CHCl3  (53.84%) 
> n-hexane = EtOAc = BuOH = aqueous (50.00%). 
Against S. aureus; CHCl3 (60.00%) > n-hexane (56.0 %) 
> EtOAc (52.0%) > crude extract = aqueous (48.0%) > 
BuOH (44.0 %). The activity against P. aeruginosa was: 
crude extract (60.0%) > CHCl3 = BuOH (56.0 %) > n-
hexane (52.0%) > EtOAc = aqueous (48.0%). Against K. 
pneumoniae: crude extract = CHCl3 (68.42%) > n-hexane 
(63.15%) > EtOAc = aqueous (57.89%) > BuOH 
(47.36%). Against B. pumilus: crude extract (54.83%) > 
aqueous (51.61%) > BuOH (48.38%) > n-hexane = 
CHCl3 (45.16%), while the EtOAc fraction of plant extract 
shows no activity. The activity of the test samples against 
E. aerogenes was in order of: crude extract (40.62%) > n-
hexane = CHCl3 (37.50 %) > EtOAc (34.37%), while 
BuOH and aqueous fractions were found inactive against 
E. aerogenes. From the above results, it is revealed that 
crude methanolic extract, CHCl3 and n-hexane fractions 
showed good antibacterial activity against K. pneumoniae, 
while other fractions showed moderate to low and no 
activity against the tested pathogens. The lower the 
MIC50 values, the higher will be its potency and vice 
versa. The MIC50 values (mg/ml) of the crude methanolic 
extract and all fractions were calculated from three 
separate reading by using a Microsoft XL sheet, which 
are summarized in Figure 3. Interestingly, highest activity 
(100%) was displayed by the CHCl3 fraction against P. 
aeruginosa,   n-hexane  fraction  against  K.  pneumoniae  












Figure 3.  MIC50 values (mg/ml) of the crude methanolic extract and various fractions of M. africana.  
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and S.pneumoniae. The research can further be 
proceeded to isolate the natural bioactive anti-






Certain plants have been found to contain 
haemagglutinins in their different parts, which can 
be extracted and used for the production of blood 
typing reagents in the same way as agglutinins 
from animal sources. The plant source agglutinins 
have advantage over the animal sources because 
they are economical and available in large quanti-
ties. Each test samples, crude methanolic extract 
and fractions of M. africana with different dilutions 
was screened for possible haemagglutination 
activity against human erythrocytes of all blood 
groups (ABO). The results showed that crude 
methanolic extract and CHCl3 have moderate (
++
) 
haemagglutination effect against AB
-
 blood group 
and aqueous fraction have moderate activity 
against O
+
 blood groups at higher concentrations 
(1:2). Weak (
+
) activity was also observed against 
the erythrocytes of other blood groups at dilution 
of 1:2 and 1:4. The n-hexane and EtOAc fractions 
showed no haemag-glutination activity against 
human red blood cells of all blood groups. Results 
are summarized in Table 1. The present investi-
gation reveals that that the plant contains lectins 
and could be a useful source of phytolectins. It is 
concluded that plant species could be a potential 
target for activity guided isolation of antibacterial 
and phytotoxic agent(s).  The plant can also be a 
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